Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-02

Clinical Trial Update: Teneligliptin-Glimepiride DDI Study [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating potential drug-drug interaction between teneligliptin and glimepiride has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • Teneligliptin (Teneligliptin)

Snippet

Sponsor: Handok Inc. | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED